Effect of low dose weekly methotrexate on bone mineral density and bone turnover
Identifieur interne : 007F97 ( Main/Curation ); précédent : 007F96; suivant : 007F98Effect of low dose weekly methotrexate on bone mineral density and bone turnover
Auteurs : S. Patel [Royaume-Uni] ; G. Patel [Royaume-Uni] ; D. Johnson [Royaume-Uni] ; L. Ogunremi [Royaume-Uni] ; J. BarronSource :
- Annals of the Rheumatic Diseases [ 0003-4967 ] ; 2003-02.
Descripteurs français
- Wicri :
- topic : Maladie cardio-vasculaire, Chiffre d'affaires.
English descriptors
- KwdEn :
- Aanxv, Abnormality, Aicher, American college, Ankylosing, Ankylosing spondylitis, Antinuclear antibodies, Antiphospholipid antibodies, Antiphospholipid syndrome, Apnoea syndrome, Arteritis, Arthritis, Arthritis rheum, Basdai, Baseline, Bath ankylosing spondylitis disease activity index, Bone density, Bone markers, Bone mineral density, Bone turnover, Bronchoalveolar lavage, Cardiovascular disease, Cell viability, Centre, Cervical spine disease, Chest expansion, Chest hrct, Chest radiographs, Clin, Clinical manifestations, Consecutive patients, Control group, Corticosteroid treatment, Daytime sleepiness, Depression scale, Diagnostic criteria, Disease activity, Dmard treatment, Dudley group, Encoding, Encoding mrna, Encoding transcripts, Eosinophilic fasciitis, Epworth sleepiness scale, Erythrocyte sedimentation rate, Fatigue component, Femoral neck, Fetal loss, Fibroblast, Fracture, Further studies, Giant cell arteritis, Healthy control subjects, Healthy controls, Helier hospital, Hospital anxiety, Hrct, Immunosorbent assay, Interstitial, Interstitial abnormalities, Interstitial lung disease, June, Kinase, Letters authors, Ligand, Longitudinal phase, Longitudinal study, Lumbar spine, Lupus, Lupus anticoagulant, Lymphocyte, Methotrexate, Mild right, Military hospital mohamed, Neck circumference, Negative control, Night oximetry, Okadaic acid, Orthopaedic surgery, Other factors, Other hand, Overall basdai scores, Phorbol ester, Plain radiography, Polynuclear neutrophils, Positive control, Product sizes, Protein kinase, Protein kinase inhibitor staurosporine, Psoriatic arthritis, Pulmonary function testing, Reactive protein, Respiratory symptoms, Rheum, Rheumatoid, Rheumatoid arthritis, Rheumatol, Rheumatology, Risk factors, Second passage, Serum levels, Serum samples, Skeletal sites, Sleepiness, Spinal involvement, Spondylitis, Staurosporine, Stress fracture, Syndrome, Synovial, Synovial fibroblasts, Systemic, Systemic disease, Systemic lupus erythematosus, Temporal arteritis, Turbidimetric immunoassay, Turnover, Untreated cells, Variable effects, York criteria, Young patients, bone mineral density, bone turnover, methotrexate.
- Teeft :
- Aanxv, Abnormality, Aicher, American college, Ankylosing, Ankylosing spondylitis, Antinuclear antibodies, Antiphospholipid antibodies, Antiphospholipid syndrome, Apnoea syndrome, Arteritis, Arthritis, Arthritis rheum, Basdai, Baseline, Bath ankylosing spondylitis disease activity index, Bone density, Bone markers, Bone mineral density, Bone turnover, Bronchoalveolar lavage, Cardiovascular disease, Cell viability, Centre, Cervical spine disease, Chest expansion, Chest hrct, Chest radiographs, Clin, Clinical manifestations, Consecutive patients, Control group, Corticosteroid treatment, Daytime sleepiness, Depression scale, Diagnostic criteria, Disease activity, Dmard treatment, Dudley group, Encoding, Encoding mrna, Encoding transcripts, Eosinophilic fasciitis, Epworth sleepiness scale, Erythrocyte sedimentation rate, Fatigue component, Femoral neck, Fetal loss, Fibroblast, Fracture, Further studies, Giant cell arteritis, Healthy control subjects, Healthy controls, Helier hospital, Hospital anxiety, Hrct, Immunosorbent assay, Interstitial, Interstitial abnormalities, Interstitial lung disease, June, Kinase, Letters authors, Ligand, Longitudinal phase, Longitudinal study, Lumbar spine, Lupus, Lupus anticoagulant, Lymphocyte, Methotrexate, Mild right, Military hospital mohamed, Neck circumference, Negative control, Night oximetry, Okadaic acid, Orthopaedic surgery, Other factors, Other hand, Overall basdai scores, Phorbol ester, Plain radiography, Polynuclear neutrophils, Positive control, Product sizes, Protein kinase, Protein kinase inhibitor staurosporine, Psoriatic arthritis, Pulmonary function testing, Reactive protein, Respiratory symptoms, Rheum, Rheumatoid, Rheumatoid arthritis, Rheumatol, Rheumatology, Risk factors, Second passage, Serum levels, Serum samples, Skeletal sites, Sleepiness, Spinal involvement, Spondylitis, Staurosporine, Stress fracture, Syndrome, Synovial, Synovial fibroblasts, Systemic, Systemic disease, Systemic lupus erythematosus, Temporal arteritis, Turbidimetric immunoassay, Turnover, Untreated cells, Variable effects, York criteria, Young patients.
Url:
DOI: 10.1136/ard.62.2.186
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003D73
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :003D73
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003623
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :008232
Links to Exploration step
ISTEX:7CE2C9AC064D5A5C9B08093C5B5EF5603CC8B64FCuration
No country items
J. Barron<affiliation><wicri:noCountry code="subField">Hospital</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effect of low dose weekly methotrexate on bone mineral density and bone turnover</title>
<author><name sortKey="Patel, S" sort="Patel, S" uniqKey="Patel S" first="S" last="Patel">S. Patel</name>
</author>
<author><name sortKey="Patel, G" sort="Patel, G" uniqKey="Patel G" first="G" last="Patel">G. Patel</name>
</author>
<author><name sortKey="Johnson, D" sort="Johnson, D" uniqKey="Johnson D" first="D" last="Johnson">D. Johnson</name>
</author>
<author><name sortKey="Ogunremi, L" sort="Ogunremi, L" uniqKey="Ogunremi L" first="L" last="Ogunremi">L. Ogunremi</name>
</author>
<author><name sortKey="Barron, J" sort="Barron, J" uniqKey="Barron J" first="J" last="Barron">J. Barron</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7CE2C9AC064D5A5C9B08093C5B5EF5603CC8B64F</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1136/ard.62.2.186</idno>
<idno type="url">https://api.istex.fr/document/7CE2C9AC064D5A5C9B08093C5B5EF5603CC8B64F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003D73</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">003D73</idno>
<idno type="wicri:Area/Istex/Curation">003D73</idno>
<idno type="wicri:Area/Istex/Checkpoint">003623</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">003623</idno>
<idno type="wicri:doubleKey">0003-4967:2003:Patel S:effect:of:low</idno>
<idno type="wicri:Area/Main/Merge">008232</idno>
<idno type="wicri:Area/Main/Curation">007F97</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Effect of low dose weekly methotrexate on bone mineral density and bone turnover</title>
<author><name sortKey="Patel, S" sort="Patel, S" uniqKey="Patel S" first="S" last="Patel">S. Patel</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Rheumatology, St Helier Hospital, Epsom and St Helier NHS Trust</wicri:regionArea>
<wicri:noRegion>Epsom and St Helier NHS Trust</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Osteoporosis Unit, Department of Rheumatology, St George’s Hospital</wicri:regionArea>
<wicri:noRegion>St George’s Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Patel, G" sort="Patel, G" uniqKey="Patel G" first="G" last="Patel">G. Patel</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Rheumatology, St Helier Hospital, Epsom and St Helier NHS Trust</wicri:regionArea>
<wicri:noRegion>Epsom and St Helier NHS Trust</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Johnson, D" sort="Johnson, D" uniqKey="Johnson D" first="D" last="Johnson">D. Johnson</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Rheumatology, St Helier Hospital, Epsom and St Helier NHS Trust</wicri:regionArea>
<wicri:noRegion>Epsom and St Helier NHS Trust</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ogunremi, L" sort="Ogunremi, L" uniqKey="Ogunremi L" first="L" last="Ogunremi">L. Ogunremi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Osteoporosis Unit, Department of Rheumatology, St George’s Hospital</wicri:regionArea>
<wicri:noRegion>St George’s Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Barron, J" sort="Barron, J" uniqKey="Barron J" first="J" last="Barron">J. Barron</name>
<affiliation><wicri:noCountry code="subField">Hospital</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Annals of the Rheumatic Diseases</title>
<title level="j" type="abbrev">Ann Rheum Dis</title>
<idno type="ISSN">0003-4967</idno>
<idno type="eISSN">1468-2060</idno>
<imprint><publisher>BMJ Publishing Group Ltd and European League Against Rheumatism</publisher>
<date type="published" when="2003-02">2003-02</date>
<biblScope unit="volume">62</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="186">186</biblScope>
</imprint>
<idno type="ISSN">0003-4967</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0003-4967</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aanxv</term>
<term>Abnormality</term>
<term>Aicher</term>
<term>American college</term>
<term>Ankylosing</term>
<term>Ankylosing spondylitis</term>
<term>Antinuclear antibodies</term>
<term>Antiphospholipid antibodies</term>
<term>Antiphospholipid syndrome</term>
<term>Apnoea syndrome</term>
<term>Arteritis</term>
<term>Arthritis</term>
<term>Arthritis rheum</term>
<term>Basdai</term>
<term>Baseline</term>
<term>Bath ankylosing spondylitis disease activity index</term>
<term>Bone density</term>
<term>Bone markers</term>
<term>Bone mineral density</term>
<term>Bone turnover</term>
<term>Bronchoalveolar lavage</term>
<term>Cardiovascular disease</term>
<term>Cell viability</term>
<term>Centre</term>
<term>Cervical spine disease</term>
<term>Chest expansion</term>
<term>Chest hrct</term>
<term>Chest radiographs</term>
<term>Clin</term>
<term>Clinical manifestations</term>
<term>Consecutive patients</term>
<term>Control group</term>
<term>Corticosteroid treatment</term>
<term>Daytime sleepiness</term>
<term>Depression scale</term>
<term>Diagnostic criteria</term>
<term>Disease activity</term>
<term>Dmard treatment</term>
<term>Dudley group</term>
<term>Encoding</term>
<term>Encoding mrna</term>
<term>Encoding transcripts</term>
<term>Eosinophilic fasciitis</term>
<term>Epworth sleepiness scale</term>
<term>Erythrocyte sedimentation rate</term>
<term>Fatigue component</term>
<term>Femoral neck</term>
<term>Fetal loss</term>
<term>Fibroblast</term>
<term>Fracture</term>
<term>Further studies</term>
<term>Giant cell arteritis</term>
<term>Healthy control subjects</term>
<term>Healthy controls</term>
<term>Helier hospital</term>
<term>Hospital anxiety</term>
<term>Hrct</term>
<term>Immunosorbent assay</term>
<term>Interstitial</term>
<term>Interstitial abnormalities</term>
<term>Interstitial lung disease</term>
<term>June</term>
<term>Kinase</term>
<term>Letters authors</term>
<term>Ligand</term>
<term>Longitudinal phase</term>
<term>Longitudinal study</term>
<term>Lumbar spine</term>
<term>Lupus</term>
<term>Lupus anticoagulant</term>
<term>Lymphocyte</term>
<term>Methotrexate</term>
<term>Mild right</term>
<term>Military hospital mohamed</term>
<term>Neck circumference</term>
<term>Negative control</term>
<term>Night oximetry</term>
<term>Okadaic acid</term>
<term>Orthopaedic surgery</term>
<term>Other factors</term>
<term>Other hand</term>
<term>Overall basdai scores</term>
<term>Phorbol ester</term>
<term>Plain radiography</term>
<term>Polynuclear neutrophils</term>
<term>Positive control</term>
<term>Product sizes</term>
<term>Protein kinase</term>
<term>Protein kinase inhibitor staurosporine</term>
<term>Psoriatic arthritis</term>
<term>Pulmonary function testing</term>
<term>Reactive protein</term>
<term>Respiratory symptoms</term>
<term>Rheum</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatol</term>
<term>Rheumatology</term>
<term>Risk factors</term>
<term>Second passage</term>
<term>Serum levels</term>
<term>Serum samples</term>
<term>Skeletal sites</term>
<term>Sleepiness</term>
<term>Spinal involvement</term>
<term>Spondylitis</term>
<term>Staurosporine</term>
<term>Stress fracture</term>
<term>Syndrome</term>
<term>Synovial</term>
<term>Synovial fibroblasts</term>
<term>Systemic</term>
<term>Systemic disease</term>
<term>Systemic lupus erythematosus</term>
<term>Temporal arteritis</term>
<term>Turbidimetric immunoassay</term>
<term>Turnover</term>
<term>Untreated cells</term>
<term>Variable effects</term>
<term>York criteria</term>
<term>Young patients</term>
<term>bone mineral density</term>
<term>bone turnover</term>
<term>methotrexate</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Aanxv</term>
<term>Abnormality</term>
<term>Aicher</term>
<term>American college</term>
<term>Ankylosing</term>
<term>Ankylosing spondylitis</term>
<term>Antinuclear antibodies</term>
<term>Antiphospholipid antibodies</term>
<term>Antiphospholipid syndrome</term>
<term>Apnoea syndrome</term>
<term>Arteritis</term>
<term>Arthritis</term>
<term>Arthritis rheum</term>
<term>Basdai</term>
<term>Baseline</term>
<term>Bath ankylosing spondylitis disease activity index</term>
<term>Bone density</term>
<term>Bone markers</term>
<term>Bone mineral density</term>
<term>Bone turnover</term>
<term>Bronchoalveolar lavage</term>
<term>Cardiovascular disease</term>
<term>Cell viability</term>
<term>Centre</term>
<term>Cervical spine disease</term>
<term>Chest expansion</term>
<term>Chest hrct</term>
<term>Chest radiographs</term>
<term>Clin</term>
<term>Clinical manifestations</term>
<term>Consecutive patients</term>
<term>Control group</term>
<term>Corticosteroid treatment</term>
<term>Daytime sleepiness</term>
<term>Depression scale</term>
<term>Diagnostic criteria</term>
<term>Disease activity</term>
<term>Dmard treatment</term>
<term>Dudley group</term>
<term>Encoding</term>
<term>Encoding mrna</term>
<term>Encoding transcripts</term>
<term>Eosinophilic fasciitis</term>
<term>Epworth sleepiness scale</term>
<term>Erythrocyte sedimentation rate</term>
<term>Fatigue component</term>
<term>Femoral neck</term>
<term>Fetal loss</term>
<term>Fibroblast</term>
<term>Fracture</term>
<term>Further studies</term>
<term>Giant cell arteritis</term>
<term>Healthy control subjects</term>
<term>Healthy controls</term>
<term>Helier hospital</term>
<term>Hospital anxiety</term>
<term>Hrct</term>
<term>Immunosorbent assay</term>
<term>Interstitial</term>
<term>Interstitial abnormalities</term>
<term>Interstitial lung disease</term>
<term>June</term>
<term>Kinase</term>
<term>Letters authors</term>
<term>Ligand</term>
<term>Longitudinal phase</term>
<term>Longitudinal study</term>
<term>Lumbar spine</term>
<term>Lupus</term>
<term>Lupus anticoagulant</term>
<term>Lymphocyte</term>
<term>Methotrexate</term>
<term>Mild right</term>
<term>Military hospital mohamed</term>
<term>Neck circumference</term>
<term>Negative control</term>
<term>Night oximetry</term>
<term>Okadaic acid</term>
<term>Orthopaedic surgery</term>
<term>Other factors</term>
<term>Other hand</term>
<term>Overall basdai scores</term>
<term>Phorbol ester</term>
<term>Plain radiography</term>
<term>Polynuclear neutrophils</term>
<term>Positive control</term>
<term>Product sizes</term>
<term>Protein kinase</term>
<term>Protein kinase inhibitor staurosporine</term>
<term>Psoriatic arthritis</term>
<term>Pulmonary function testing</term>
<term>Reactive protein</term>
<term>Respiratory symptoms</term>
<term>Rheum</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatol</term>
<term>Rheumatology</term>
<term>Risk factors</term>
<term>Second passage</term>
<term>Serum levels</term>
<term>Serum samples</term>
<term>Skeletal sites</term>
<term>Sleepiness</term>
<term>Spinal involvement</term>
<term>Spondylitis</term>
<term>Staurosporine</term>
<term>Stress fracture</term>
<term>Syndrome</term>
<term>Synovial</term>
<term>Synovial fibroblasts</term>
<term>Systemic</term>
<term>Systemic disease</term>
<term>Systemic lupus erythematosus</term>
<term>Temporal arteritis</term>
<term>Turbidimetric immunoassay</term>
<term>Turnover</term>
<term>Untreated cells</term>
<term>Variable effects</term>
<term>York criteria</term>
<term>Young patients</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Maladie cardio-vasculaire</term>
<term>Chiffre d'affaires</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007F97 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 007F97 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= EdenteV2 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:7CE2C9AC064D5A5C9B08093C5B5EF5603CC8B64F |texte= Effect of low dose weekly methotrexate on bone mineral density and bone turnover }}
![]() | This area was generated with Dilib version V0.6.32. | ![]() |